ROCKET PHARMACEUTICALS, INC. - Common Stock (RCKT)
CUSIP: 77313F106
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 109,265,652
- Total 13F shares
- 92,703,462
- Share change
- +1,244,045
- Total reported value
- $1,709,382,927
- Put/Call ratio
- 33%
- Price per share
- $18.47
- Number of holders
- 189
- Value change
- +$19,027,944
- Number of buys
- 94
- Number of sells
- 71
Quarterly Holders Quick Answers
What is CUSIP 77313F106?
CUSIP 77313F106 identifies RCKT - ROCKET PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 77313F106:
Top shareholders of RCKT - ROCKET PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP |
13F
|
Company |
—
mixed-class rows
|
18,037,772
mixed-class rows
|
$380,838,976 | — | 30 Jun 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
8.4%
|
9,155,720
|
$197,122,652 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
5.7%
|
6,192,627
|
$133,327,260 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.3%
|
5,808,550
|
$125,058,083 | — | 30 Jun 2024 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
4%
|
4,327,922
|
$93,180,161 | — | 30 Jun 2024 | |
| MAVERICK CAPITAL LTD |
13F
|
Company |
3.6%
|
3,928,312
|
$84,576,557 | — | 30 Jun 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.9%
|
3,169,448
|
$68,239,000 | — | 30 Jun 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
2.7%
|
2,919,078
|
$62,842,455 | — | 30 Jun 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
—
mixed-class rows
|
3,188,668
mixed-class rows
|
$60,695,373 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.5%
|
2,779,866
|
$59,850,515 | — | 30 Jun 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.7%
|
1,873,689
|
$40,340,524 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
1,603,610
|
$34,532,870 | — | 30 Jun 2024 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
1.4%
|
1,561,230
|
$33,613,282 | — | 30 Jun 2024 | |
| Boxer Capital, LLC |
13F
|
Company |
1.3%
|
1,466,051
|
$31,564,078 | — | 30 Jun 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
1.1%
|
1,246,597
|
$26,839,233 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.1%
|
1,238,044
|
$26,655,088 | — | 30 Jun 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
1.1%
|
1,226,387
|
$26,404,112 | — | 30 Jun 2024 | |
| Avidity Partners Management LP |
13F
|
Company |
1%
|
1,100,000
|
$23,683,000 | — | 30 Jun 2024 | |
| COWEN AND COMPANY, LLC |
13F
|
Company |
1%
|
1,100,000
|
$23,683,000 | — | 30 Jun 2024 | |
| Novo Holdings A/S |
13F
|
Company |
1%
|
1,100,000
|
$23,683,000 | — | 30 Jun 2024 | |
| BAMCO INC /NY/ |
13F
|
Company |
0.9%
|
979,331
|
$21,084,996 | — | 30 Jun 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.87%
|
946,175
|
$20,371,192 | — | 30 Jun 2024 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.71%
|
770,691
|
$16,592,977 | — | 30 Jun 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.69%
|
750,000
|
$16,147,500 | — | 30 Jun 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.64%
|
695,908
|
$14,982,890 | — | 30 Jun 2024 | |
| COMERICA BANK |
13F
|
Company |
0.63%
|
686,654
|
$14,783,661 | — | 30 Jun 2024 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.62%
|
677,744
|
$14,591,838 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.54%
|
588,597
|
$12,672,494 | — | 30 Jun 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.53%
|
579,738
|
$12,481,759 | — | 30 Jun 2024 | |
| FMR LLC |
13F
|
Company |
0.53%
|
579,279
|
$12,471,876 | — | 30 Jun 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.51%
|
561,966
|
$12,099,128 | — | 30 Jun 2024 | |
| First Turn Management, LLC |
13F
|
Company |
0.51%
|
560,989
|
$12,078,093 | — | 30 Jun 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.5%
|
549,492
|
$11,830,563 | — | 30 Jun 2024 | |
| EcoR1 Capital, LLC |
13F
|
Company |
0.47%
|
508,393
|
$10,945,701 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.44%
|
475,988
|
$10,248,023 | — | 30 Jun 2024 | |
| UBS Group AG |
13F
|
Company |
—
mixed-class rows
|
405,806
mixed-class rows
|
$8,736,487 | — | 30 Jun 2024 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.35%
|
386,996
|
$8,332,024 | — | 30 Jun 2024 | |
| M28 Capital Management LP |
13F
|
Company |
0.35%
|
385,680
|
$8,303,690 | — | 30 Jun 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.32%
|
352,026
|
$7,579,120 | — | 30 Jun 2024 | |
| Logos Global Management LP |
13F
|
Company |
0.32%
|
350,000
|
$7,535,500 | — | 30 Jun 2024 | |
| WCM INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.27%
|
292,901
|
$6,276,868 | — | 30 Jun 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.24%
|
261,347
|
$5,626,801 | — | 30 Jun 2024 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.23%
|
250,370
|
$5,390,466 | — | 30 Jun 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.22%
|
239,877
|
$5,164,556 | — | 30 Jun 2024 | |
| Privium Fund Management B.V. |
13F
|
Company |
0.23%
|
250,980
|
$4,964,384 | — | 30 Jun 2024 | |
| EFG Asset Management (North America) Corp. |
13F
|
Company |
0.2%
|
222,046
|
$4,779,540 | — | 30 Jun 2024 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.19%
|
206,933
|
$4,455,267 | — | 30 Jun 2024 | |
| Hennion & Walsh Asset Management, Inc. |
13F
|
Company |
0.19%
|
204,110
|
$4,394,488 | — | 30 Jun 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.18%
|
200,000
|
$4,306,000 | — | 30 Jun 2024 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.18%
|
198,771
|
$4,279,096 | — | 30 Jun 2024 |
Institutional Holders of ROCKET PHARMACEUTICALS, INC. - Common Stock (RCKT) as of Q3 2024
As of 30 Sep 2024,
ROCKET PHARMACEUTICALS, INC. - Common Stock (RCKT) was held by
189 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
92,703,462 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, WELLINGTON MANAGEMENT GROUP LLP, BlackRock, Inc., VANGUARD GROUP INC, WESTFIELD CAPITAL MANAGEMENT CO LP, MAVERICK CAPITAL LTD, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, CITADEL ADVISORS LLC, and JANUS HENDERSON GROUP PLC.
This page lists
190
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
176
Q3 2024 holders
189
Holder diff
13
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.